CN1180808C - Chinese medicine for treating rheumatic and rheumatoid diseases - Google Patents
Chinese medicine for treating rheumatic and rheumatoid diseases Download PDFInfo
- Publication number
- CN1180808C CN1180808C CNB011317426A CN01131742A CN1180808C CN 1180808 C CN1180808 C CN 1180808C CN B011317426 A CNB011317426 A CN B011317426A CN 01131742 A CN01131742 A CN 01131742A CN 1180808 C CN1180808 C CN 1180808C
- Authority
- CN
- China
- Prior art keywords
- grams
- roots
- radix
- medicine
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 201000010099 disease Diseases 0.000 title abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 6
- 208000025747 Rheumatic disease Diseases 0.000 title 1
- 230000000552 rheumatic effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- 241001098027 Callerya speciosa Species 0.000 claims description 7
- 241001655727 Celastrus orbiculatus Species 0.000 claims description 7
- 241000903946 Clematidis Species 0.000 claims description 7
- 239000009670 cang er zi wan Substances 0.000 claims description 7
- 241001506304 Kadsura japonica Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 210000003205 muscle Anatomy 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 235000007650 Aralia spinosa Nutrition 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 240000000425 Chaenomeles speciosa Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000195955 Equisetum hyemale Species 0.000 abstract 1
- 241000521581 Millettia Species 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 241000727913 Parthenocissus tricuspidata Species 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 241000949456 Zanthoxylum Species 0.000 abstract 1
- 230000036783 anaphylactic response Effects 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000002574 poison Substances 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241001251068 Formica fusca Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention belongs to medicine for treating rheumatism and rheumatoid disease, which provides pure Chinese medicine preparation for treating the rheumatism and the rheumatoid disease. The present invention has the key point that the Chinese medicine preparation of the present invention is composed of orientvine stems, futokadsura stems, clematis roots, spinyleaf pricklyash roots, beautiful millettia roots, pubescent angelica roots, gall roots, boston ivy, shave grass, common floweringquince roots, madder roots, cocklebur fruit, bupleurum roots, caulis polygoni multiflori, dahurian angelica roots, pueraria roots and grassleaved sweetflag rhizomes. All the medicine is prepared with crude medicine; each kind of medicine has the proportion by weight of 3 to 5. The preparation has the functions of eliminating swelling, promoting tissue regeneration, dredging channels, dispelling wind, eliminating dampness, nourishing livers and kidneys, strengthening bones and muscles, stretching joints and relieving crymodynia. Compared with the prior art, the present invention has no anaphylaxis and has no poison and side effects on human bodies; the cure rate is over 90%. The medicine has the advantages of richness and easy acquisition of medicinal resources, low price and economy for patients.
Description
Technical field
The invention belongs to treatment rheumatism, rheumatoid medicine, specifically a kind of rheumatism, rheumatoid Chinese medicine preparation of being used for the treatment of.
Background technology
Rheumatism is one of commonly encountered diseases frequently-occurring disease of serious harm people's health.Treat this sick method a few days ago and have two kinds, a kind of is doctor trained in Western medicine, think that this disease is because human body Hemolytic streptococcus or viral infection cause, the medicine of anti-inflammatory analgesic is adopted in treatment usually, as salicylic acid preparation, ibuprofen, piroxicam and adrenocortical steroid and immunosuppressant etc., these medicines mostly can only relief of symptoms, can not effect a radical cure, and toxic side effect is taken for a long time, and patient's the heart, liver, kidney, gastrointestinal tract and reproductive system all had tangible detrimental effect.Another kind of is treatment by Chinese herbs, as the patent No. is 97114453, " a kind of treatment rheumatism, rheumatoid Chinese medicine preparation and preparation method thereof " disclosed preparation by name, its component has Formica fusca, Rhizoma Curculiginis, Semen Sinapis Albae (parched), Zaocys, Rhizoma Gastrodiae, Herba Ephedrae, Cortex Cinnamomi, Cornu Cervi Degelatinatum, stir-baked SQUAMA MANITIS, Radix Angelicae Sinensis, Radix Notoginseng, Os Draconis, Rhizoma Zingiberis.And for example the patent No. is 97115872, " a kind of pure Chinese medicine capsule for the treatment of the rheumatism of class " disclosed Chinese medicine preparation by name, and its composition has Semen Strychni (processed), Semen daturae and Pyritum (calcined).The described patent No. is to contain the wild Squama Manis that watches for animals of national secondary in 97114453 the preparation, and use is restricted; The patent No. is to contain the bigger Semen Strychni of toxic side effect in 97115872 the preparation, general in dose few, and can not use for a long time, if dose is big, limbs vibration, paralysis can appear, anemia of pregnant woman, body void and taste weak person avoid clothes.
Summary of the invention
The present invention is for overcoming the deficiency of prior art, proposes a kind ofly to have no side effect, the treatment rheumatism of medication economy, rheumatoid Chinese medicine preparation.
Chinese medicine preparation of the present invention is formed with following components by part by weight: 25 parts of Caulis Sinomeniis, 25 parts of Caulis Piperis Kadsuraes, Radix Clematidis 15-25 part, Folium Salicis Babylonicae Radix Zanthoxyli Spinifolii 15-20 part, Millettia Speciosa 15-20 part, Radix Angelicae Pubescentis 14-20 part, Galla Chinensis root 12-20 part is stung luxuriant Celastrus orbiculatus Thunb. 15-25 part, Herba Equiseti Hiemalis 20-25 part, Radix Chaenomelis 15-20 part, Radix Rubiae 13-20 part, Fructus Xanthii 15-20 part, Radix Bupleuri 15-20 part, Caulis Polygoni Multiflori 15-20 part, Radix Angelicae Dahuricae 16-25 part, Radix Puerariae 15-25 part, Rhizoma Acori Graminei 15-25 part.During use, pulverize by weight ratio and be powder that can be oral, be made as capsule or pill, every day, consumption was no more than 100 grams, and each consumption is the 15-25 gram.
The technical scheme that the present invention deals with problems is to learn understanding and the Therapeutic Principle that rheumatism is fallen ill according to motherland's Chinese medicine, select expelling wind and removing dampness class, suppressing the hyperactive liver to relieve the wind syndrome class, blood circulation promoting and blood stasis dispelling class, removing dampness class, the Xin Wen cold class Chinese herbal medicine that dispels the wind for use, energy detumescence and promoting granulation collateral dredging, expelling wind and removing dampness, invigorating the liver and kidney, bone and muscle strengthening, cold type of pain is ended in sharp joint.Compared with prior art, do not have the taboo of " anti-fear ", human body is had no side effect, cure rate reaches more than 90%; The used medicine medicine of the present invention source is rich and easy to get, cheap, patient's medication economy.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Example formulations 1
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 25 grams, Folium Salicis Babylonicae Radix Zanthoxyli Spinifolii 15 grams, Millettia Speciosa 17 grams, Radix Angelicae Pubescentis 16 grams, Galla Chinensis root 20 grams, luxuriant Celastrus orbiculatus Thunb. 25 grams of thorn, Herba Equiseti Hiemalis's 25 grams, Radix Chaenomelis 20 grams, Radix Rubiae 18 grams, Fructus Xanthii 15 grams, Radix Bupleuri 20 grams, Caulis Polygoni Multiflori 17 grams, the Radix Angelicae Dahuricae 16 grams, Radix Puerariae 20 grams and Rhizoma Acori Graminei 25 grams.
Example formulations 2
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 15 grams, Folium Salicis Babylonicae Radix Zanthoxyli Spinifolii 18 grams, Millettia Speciosa 16 grams, Radix Angelicae Pubescentis 15 grams, Galla Chinensis root 15 grams, luxuriant Celastrus orbiculatus Thunb. 20 grams of thorn, Herba Equiseti Hiemalis's 20 grams, Radix Chaenomelis 15 grams, Radix Rubiae 20 grams, Fructus Xanthii 15 grams, Radix Bupleuri 15 grams, Caulis Polygoni Multiflori 15 grams, the Radix Angelicae Dahuricae 20 grams, Radix Puerariae 25 grams and Rhizoma Acori Graminei 20 grams.
Example formulations 3
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 20 grams, Folium Salicis Babylonicae Radix Zanthoxyli Spinifolii 20 grams, Millettia Speciosa 15 grams, Radix Angelicae Pubescentis 20 grams, Galla Chinensis root 15 grams, luxuriant Celastrus orbiculatus Thunb. 25 grams of thorn, Herba Equiseti Hiemalis's 20 grams, Radix Chaenomelis 20 grams, Radix Rubiae 15 grams, Fructus Xanthii 16 grams, Radix Bupleuri 20 grams, Caulis Polygoni Multiflori 15 grams, the Radix Angelicae Dahuricae 25 grams, Radix Puerariae 20 grams and Rhizoma Acori Graminei 25 grams.
Example formulations 4
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 20 grams, Folium Salicis Babylonicae Radix Zanthoxyli Spinifolii 15 grams, Millettia Speciosa 15 grams, Radix Angelicae Pubescentis 14 grams, Galla Chinensis root 12 grams, luxuriant Celastrus orbiculatus Thunb. 20 grams of thorn, Herba Equiseti Hiemalis's 25 grams, Radix Chaenomelis 15 grams, Radix Rubiae 13 grams, Fructus Xanthii 15 grams, Radix Bupleuri 15 grams, Caulis Polygoni Multiflori 20 grams, the Radix Angelicae Dahuricae 20 grams, Radix Puerariae 15 grams and Rhizoma Acori Graminei 15 grams.
Example formulations 5
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 20 grams, Folium Salicis Babylonicae Radix Zanthoxyli Spinifolii 20 grams, Millettia Speciosa 20 grams, Radix Angelicae Pubescentis, Galla Chinensis root 20 grams, luxuriant Celastrus orbiculatus Thunb. 15 grams of thorn, Herba Equiseti Hiemalis's 20 grams, Radix Chaenomelis 20 grams, Radix Rubiae 15 grams, Fructus Xanthii 20 grams, Radix Bupleuri 20 grams, Caulis Polygoni Multiflori 20 grams, the Radix Angelicae Dahuricae 18 grams, Radix Puerariae 20 grams and Rhizoma Acori Graminei 25 grams.
Chinese medicine title of the present invention comes from " national Chinese herbal medicine compilation " (the limitting domestic distribution) that the People's Health Publisher publishes in April, 1978.
Claims (1)
- Treat rheumatism, rheumatoid Chinese medicine preparation for 1 one kinds, it is characterized in that it is made up of following components by part by weight: 25 parts of Caulis Sinomeniis, 25 parts of Caulis Piperis Kadsuraes, Radix Clematidis 15-25 part, Folium Salicis Babylonicae Radix Zanthoxyli Spinifolii 15-20 part, Millettia Speciosa 15-20 part, Radix Angelicae Pubescentis 14-20 part, Galla Chinensis root 12-20 part is stung luxuriant Celastrus orbiculatus Thunb. 15-25 part, Herba Equiseti Hiemalis 20-25 part, Radix Chaenomelis 15-20 part, Radix Rubiae 13-20 part, Fructus Xanthii 15-20 part, Radix Bupleuri 15-20 part, Caulis Polygoni Multiflori 15-20 part, Radix Angelicae Dahuricae 16-25 part, Radix Puerariae 15-25 part, Rhizoma Acori Graminei 15-25 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011317426A CN1180808C (en) | 2001-09-29 | 2001-09-29 | Chinese medicine for treating rheumatic and rheumatoid diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011317426A CN1180808C (en) | 2001-09-29 | 2001-09-29 | Chinese medicine for treating rheumatic and rheumatoid diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1356128A CN1356128A (en) | 2002-07-03 |
CN1180808C true CN1180808C (en) | 2004-12-22 |
Family
ID=4670824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011317426A Expired - Fee Related CN1180808C (en) | 2001-09-29 | 2001-09-29 | Chinese medicine for treating rheumatic and rheumatoid diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1180808C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101474261B (en) * | 2008-12-03 | 2011-06-15 | 赵志库 | Chinese medicine for treating rheumatic osteonosus |
CN103933408A (en) * | 2014-05-15 | 2014-07-23 | 肖贻泰 | Traditional Chinese medicinal decoction for treating acute gouty arthritis |
-
2001
- 2001-09-29 CN CNB011317426A patent/CN1180808C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1356128A (en) | 2002-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101129817B (en) | Chinese medicine formulation for treating hypertension and method of producing the same | |
CN101161273B (en) | A Chinese patent medicine for treating catagmat | |
CN107007714B (en) | A topical medicated liquor with effect in promoting callus formation | |
CN103566278B (en) | Cortex torricelliae tiliifoliae | |
CN1260984A (en) | Exterior-applied Chinese medicine for treating trauma | |
CN1478526A (en) | Pure medicinal liquor | |
CN1180808C (en) | Chinese medicine for treating rheumatic and rheumatoid diseases | |
CN1260209A (en) | Medicine for nephritis | |
CN112618606A (en) | Traditional Chinese medicine composition for relaxing muscles and tendons and strengthening bones and preparation method thereof | |
CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
CN1054052C (en) | Comedo-elimination preparation | |
CN105012612A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
CN1141117C (en) | Aloe wine for treating injury | |
CN102872293A (en) | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease | |
CN100346807C (en) | Fuming-washing Chinese medicine for treating bone joint disease | |
CN1055845C (en) | Dieda Huoxuesan powder for curing fracture and injury | |
CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
CN1190208C (en) | Exterior-applied medical salt for treating rheumatism | |
CN106421534A (en) | Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof | |
CN1318402A (en) | Medicine for traumatic fracture pain | |
CN1113667C (en) | Medicine for treating rheumatic and rheumatoid diseases | |
CN1305508C (en) | Pill for treating coronary heart disease | |
CN106421514A (en) | Traditional Chinese medicine for treating arthralgia | |
CN116920064A (en) | Traditional Chinese medicine formula for treating rheumatic bone diseases and processing method thereof | |
CN118806689A (en) | External application Chinese medicine for treating orthopedic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Wu Dazhan Document name: Notification of Termination of Patent Right |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041222 Termination date: 20100929 |